Showing 34,642 results

Drug-resistant TB

Fewer Pills Plus Shorter Time: New Way to Control Drug-Resistant TB?

Editor's pick
MedPage Today
21 February 2022
Ageing & HIV

Marc Thompson: Still Here After All These Years

Editor's pick
Infectious Disease Special Edition
21 February 2022

CROI 2022: Screening e trattamento precoce per ridurre il cancro anale nelle persone HIV-positive, Venerdì 18 febbraio 2022

February 2022

КРОИ 2022: Скрининг и своевременная терапия предраковых изменений снижает уровень анального рака у ВИЧ-инфицированных лиц, Пятница, 18 февраля 2022 г.

February 2022

CROI 2022: Rastreio e tratamento precoce reduzem cancro anal em pessoas com VIH, Sexta-feira, 18 de fevereiro de 2022

February 2022

CROI 2022: El cribado y el tratamiento precoz reducen las tasas de cáncer anal en personas con el VIH, Viernes, 18 de febrero de 2022

February 2022

CROI 2022: Le dépistage et le traitement précoce réduisent les risques de cancer du canal anal chez les personnes séropositives, Vendredi 18 février 2022

February 2022
Violence

The link between HIV viral suppression and violence

Editor's pick
Avert
18 February 2022
Pregnancy and vertical transmission

Infant weight and height lower with efavirenz than with dolutegravir in pregnancy

News
18 February 2022

CROI 2022: Screening and early treatment reduce anal cancer in people with HIV, Friday 18 February 2022

February 2022
Pregnancy and vertical transmission

How likely is mother-to-child transmission of HIV?

About HIV
February 2022
Cancer

CROI 2022: Anal cancer Video

February 2022
HIV testing programmes & uptake

Virtual approaches boost HIV self-testing in India

News
18 February 2022
HIV treatment for children & young people

Nearly a third of babies with HIV given ART very soon after birth have no HIV antibodies two years later

News
17 February 2022
Cancer

Screening and early treatment reduce anal cancer risk by 57% in people living with HIV

News
17 February 2022
Injectable & long-acting PrEP

Injected PrEP: cabotegravir maintains its advantage over four years

News
17 February 2022
Antibody-based treatment

CROI 2022: Antibody treatment for children Video

February 2022

CROI 2022: Epatite C in calo tra le persone HIV+ grazie all’aumentato accesso alle terapie, Notizie da CROI 2022

February 2022

КРОИ 2022: Заболеваемость вирусным гепатитом С снижается среди ВИЧ-инфицированных лиц благодаря расширению доступа к терапии, Четверг, 17 февраля 2022 г.

February 2022
The search for a cure

CROI 2022: HIV remission after transplant Video

February 2022

CROI 2022: Hepatite C diminui nas pessoas com VIH à medida que o acesso ao tratamento aumenta, Quinta-feira, 17 de fevereiro de 2022

February 2022

CROI 2022: Descenso de los casos de hepatitis C en personas con el VIH al aumentar el acceso al tratamiento, Jueves, 17 de febrero de 2022

February 2022

CROI 2022: L’hépatite C recule chez les personnes séropositives avec l’élargissement de l’accès au traitement, Jeudi 17 février 2022

February 2022
Pharmaceutical industry

Gilead comes back around on Hookipa HIV partnership, signing away $15M upfront and more down the line

Editor's pick
FierceBiotech
17 February 2022